| Literature DB >> 30810535 |
Ziad El-Khatib1,2, Karin Taus1, Lukas Richter1, Franz Allerberger1, Daniela Schmid1.
Abstract
BACKGROUND: Austria has been among the main European countries hosting incoming asylum seekers since 2015. Consequently, there was an urgent need to predict any public health threats associated with the arriving asylum seekers. The Department of Surveillance and Infectious Disease Epidemiology at the Austrian Agency for Health and Food Safety (AGES) was mandated to implement a national syndrome-based surveillance system in the 7 reception centers by the Austrian Ministry of Interior and Ministry of Health.Entities:
Keywords: Austria; asylum seekers; epidemiological monitoring; mass health monitoring; population surveillance; public health surveillance; refugee health; refugees; syndrome surveillance system
Year: 2019 PMID: 30810535 PMCID: PMC6414818 DOI: 10.2196/11465
Source DB: PubMed Journal: JMIR Public Health Surveill ISSN: 2369-2960
Reception centers in Austria by duration of syndrome-based surveillance in place and number of beds.
| Province (geographical location inside Austria) | Reception center | Surveillance start date | Duration of surveillance (days) | Beds (N) |
| Lower Austria | RC1 (east) | September 2015 | 890 | 1800 |
| Tyrol | RC2 (west) | September 2015 | 873 | 200 |
| Upper Austria | RC3 (north) | October 2015 | 852 | 180 |
| Carinthia | RC4 (south) | December 2015 | 804 | 200 |
| Vienna | RC5 (east) | December 2015 | 797 | 150 |
| Styria | RC6 (south) | December 2015 | 787 | 150 |
| Salzburg | RC7 (west) | August 2016 | 538 | 160 |
List of syndromes surveilled and their definition, target diseases, and public health actiona.
| Name of syndrome | Definition of syndrome | Target disease | Public health action or measures |
| Rash with fever | Temperature ≥38.0°C and generalized rash of any nature | Measles, rubella, varicella, smallpox, louse-borne diseases (relapsing fever due to | Outbreak confirmation and investigation, contact tracing, isolation, vaccination |
| Rash without fever | N/Ab | Scabies. | N/A |
| Suspected acute upper respiratory tract infection | Fever, cough, sore throat, runny nose | Pharyngitis, tonsillitis caused by adenovirus, rhinovirus, respiratory syncytial virus, influenza, parainfluenza. | N/A |
| Suspected acute lower respiratory tract infection with fever | Temperature ≥38.0°C and at least one of the following signs or symptoms: breathing difficulties; chest rales or increased respiratory rate | Tracheitis, bronchitis, pneumonia, bronchopneumonia, or bronchiolitis, including those caused by, for example, adenovirus, streptococci, pneumococci, | Outbreak investigation in case of clustering of cases |
| Meningitis or encephalitis | Temperature ≥38.0°C and at least one of the following signs or symptoms: severe, persistent headache; neck stiffness; altered consciousness; altered mental status; confusion; delirium; or disorientation | Bacterial, viral, fungal, or other infectious meningitis or encephalitis. This could be caused by meningococci, | Outbreak confirmation and investigation, contact tracing, isolation |
| Fever and bleeding | Temperature ≥38.0°C and at least one of the following signs or symptoms: petechial rash with any purpuric areas; hemorrhagic exanthema; hematuria; conjunctival hemorrhage; gingival bleeding; epistaxis; bloody diarrhea; unexplained bleeding from other sites; or clinical suspicion of a viral hemorrhagic illness | Hemorrhagic fevers due to infectious disease agents. These could include yellow fever, dengue, or Crimean-Congo hemorrhagic fever and other arboviral diseases, Ebola. | Contact tracing, isolation |
| Non–bloody watery diarrhea | ≥3 watery stools per day, nausea, vomiting | Gastroenteritis caused by norovirus, rotavirus, bacterial toxins. | Outbreak investigation for source and vehicle, and control in case of clustering of cases |
| Bloody diarrhea | Red blood in the stool | Amoebic dysentery, | Outbreak investigation for source and vehicle, and control in case of clustering of cases |
| Acute jaundice | Acute onset of jaundice and at least one of the following signs or symptoms: temperature ≥38.0°C; malaise or hepatomegaly | Acute viral hepatitis A and E; other hepatitis. | Outbreak investigation for source and vehicle |
| Skin, soft tissue, or bone abnormalities | Skin or soft tissue lesions, ulceration, inflammation | Cutaneous diphtheria, cutaneous tuberculosis, cutaneous leishmaniasis, bacterial wound infection. | N/A |
| Acute flaccid paralysis | Person under the age of 15 years with acute flaccid nonsymmetrical paralysis | Acute flaccid paralysis, or paralytic or poliomyelitis. | Contact tracing, immunization |
| High fever with no other signs | High fever up to 40°C or more, persisting, intermittent, long-lasting | Typhoid fever; malaria, or visceral leishmaniasis. | N/A |
| Unexplained death | N/A | N/A | N/A |
aSources: European Centre for Disease Prevention and Control [4,10].
bN/A: not applicable.
Figure 1Formula for the expected daily cases (EDCs) at day t defined as the 1-sided moving average of the syndrome-specific observed daily cases (ODCs) of the previous 14 days.
Number of cases of each syndrome in total and by age group recorded by the syndrome-based surveillance system, Austria, September 2015-February 2018.
| Name of syndrome | All agesa | Age groups (years) | ||||
| 0-4 | 5-14 | 15-44 | 45-64 | ≥65 | ||
| Suspected acute URTIb, n (%) | 1469 (50.43) | 235 (75.6) | 291 (78.9) | 911 (41.81) | 31 (60) | 1 (50) |
| Rash without fever, n (%) | 1174 (40.30) | 20 (6.4) | 55 (14.9) | 1095 (50.25) | 4 (8) | 0 (0) |
| Suspected acute LRTIc with fever, n (%) | 159 (5.46) | 16 (5.1) | 12 (3.3) | 115 (5.28) | 16 (31) | 0 (0) |
| Watery diarrhea, n (%) | 73 (2.51) | 34 (10.9) | 11 (3.0) | 27 (1.24) | 1 (2) | 0 (0) |
| Skin, soft tissue, or bone abnormalities, n (%) | 32 (1.10) | 1 (0.03) | 0 (0) | 30 (1.38) | 0 (0) | 1 (50) |
| Rash with fever, n (%) | 4 (0.14) | 4 (0.13) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Meningitis or encephalitis, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| High fever (≥39°C) with no other signs, n (%) | 1 (0.03) | 0 (0) | 0 (0) | 1 (0.05) | 0 (0) | 0 (0) |
| Unexplained death, n (%) | 1 (0.03) | 1 (0.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Total (N) | 2913 | 311 | 369 | 2179 | 52 | 2 |
aOne case-patient had missing information on age.
bURTI: upper respiratory tract infection.
cLRTI: lower respiratory tract infection.
Number of cases of each syndrome, in total and stratified by reception center (RC; RC1-RC7), recorded by the syndrome-based surveillance system, Austria, September 2015-February 2018.
| Name of syndrome | All RCs | RC (by geographical location in Austria) | ||||||
| RC1 (east) | RC2 (west) | RC3 (north) | RC4 (south) | RC5 (east) | RC6 (south) | RC7 (west) | ||
| Start date | — | September 2015 | September 2015 | October 2015 | December 2015 | December 2015 | December 2015 | April 2016 |
| Suspected acute URTIa, n (%) | 1470 (50.45) | 722 (38.16) | 127 (70.6) | 250 (71.4) | 240 (83.0) | 28 (39) | 64 (73) | 39 (74) |
| Rash without fever, n (%) | 1174 (40.29) | 1031 (54.49) | 38 (21.1) | 55 (15.7) | 38 (13.2) | 6 (8) | 0 (0) | 6 (11) |
| Suspected acute LRTIb with fever, n (%) | 159 (5.46) | 84 (4.44) | 5 (2.8) | 12 (3.4) | 4 (1.4) | 26 (36) | 22 (25) | 6 (11) |
| Watery diarrhea, n (%) | 73 (2.51) | 29 (1.53) | 10 (5.6) | 30 (8.6) | 2 (0.7) | 8 (11) | 2 (2) | 2 (4) |
| Skin, soft tissue, or bone abnormalities, n (%) | 32 (1.10) | 24 (1.27) | 0 (0) | 0 (0) | 5 (1.7) | 3 (4) | 0 (0) | 0 (0) |
| Skin rash with fever, n (%) | 4 (0.14) | 0 (0) | 0 (0) | 3 (0.9) | 0 (0) | 1 (1) | 0 (0) | 0 (0) |
| Meningitis or encephalitis, n (%) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| High fever with no other signs, n (%) | 1 (0.03) | 1 (0.05) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Unexplained death, n (%) | 1 (0.03) | 1 (0.05) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Total (N) | 2914 | 1892 | 180 | 350 | 289 | 72 | 88 | 53 |
aURTI: upper respiratory tract infection.
bLRTI: lower respiratory tract infection.
Figure 2Observed daily cases of rash without fever, illustrated by gray bars, and threshold of the expected daily cases, shown by the orange line (n=151), 2015-2018, Austria.
Number of signals and alerts for each syndrome recorded by the syndrome-based surveillance system, Austria, September 2015-February 2018.
| Name of syndrome | Signals | Alerts |
| Suspected acute URTIa, n (%) | 151 (37.3) | 10 (39) |
| Rash without fever, n (%) | 142 (35.1) | 10 (39) |
| Suspected acute LRTIb with fever, n (%) | 67 (16.5) | 4 (15) |
| Watery diarrhea, n (%) | 27 (6.7) | 0 (0) |
| Skin, soft tissue, or bone abnormalities, n (%) | 14 (3.5) | 2 (8) |
| Rash with fever, n (%) | 2 (0.5) | 0 (0) |
| High fever (≥39°C) with no other signs, n (%) | 1 (0.3) | 0 (0) |
| Unexplained death, n (%) | 1 (0.3) | 0 (0) |
| Total (N) | 405 | 26 |
aURTI: upper respiratory tract infection.
bLRTI: lower respiratory tract infection.
Figure 3Selected 2 weeks of surveillance, during November 13-25, 2016, illustrating the observed daily cases of rash without fever by bars, threshold of the expected daily cases by orange line, the signals by blue squares (n=4; at November 14, 18, 19, and 23, 2016), and the alerts by a yellow triangle (n=1; at November 19, 2016).
Figure 4Numbers of signals and alerts generated by the syndrome-based surveillance system for all syndromes, per month, September 2015-February 2018, Austria.